Biotechnology

Filter

Current filters:

None

Popular Filters

2301 to 2325 of 2381 results

BioLineRx inks deal with Compugen

14-12-2011

Israeli biopharma company BioLineRx (TASE: BLRX) has entered into a collaboration with fellow Israel-based…

BioLineRxBiotechnologyCardio-vascularCompugenInflammatory diseasesLicensingOncologyPharmaceuticalResearch

More news briefs from ASH meeting

14-12-2011

In ongoing news from the American Society of Hematology (ASH) meeting taking place in San Diego, Swiss…

AmgenBiotechnologydaratumumabExjadeGenmabMerck & CoNovartisNplateOncologyPharmaceuticalResearchZolinza

Ablynx earns milestone from Merck Serono

13-12-2011

Belgium’s Ablynx (Euronext Brussels: ABLX) says it will earn a 1 million-euro ($1.3 million) from…

AblynxBiotechnologyFinancialImmunologicalsMerck KGaAMerck SeronoPharmaceuticalResearch

Actelion pulls out of Trophos option

13-12-2011

Switzerland-based Actelion (SIX: ATLN), Europe’s biggest biotech company, says that it has decided…

ActelionBiotechnologyLicensingMergers & AcquisitionsolesoximePharmaceuticalRare diseasesTrophos

Highlights of ASH meeting

13-12-2011

Among presentations at this year’s Annual Meeting of the American Society of Hematology (ASH), held…

AEterna ZentarisAriad PharmaceuticalsBiotechnologyblinatumomabMicrometOncologyperifosinePharmaceuticalPharmacyclicsponatinibResearch

Gene therapy achieves early success in hemophilia

12-12-2011

Symptoms improved significantly in adults with the hereditary bleeding disorder hemophilia B following…

BiotechnologyRare diseasesResearch

2 billion-euro EU grant for Israeli project

12-12-2011

The Joint Management Authority of the European Neighborhood and Partnership Instrument (ENPI CBC MED…

BiotechnologyEuropeFinancialResearchRest of the World

Abbott in further deal with Reata

12-12-2011

US health care major Abbott Laboratories (NYSE: ABT) has entered into a second mega-million dollar licensing…

Abbott LaboratoriesAnti-Arthritics/RheumaticsbardoxoloneBiotechnologyLicensingNeurologicalPharmaceuticalReata Pharmaceuticals

TaiGen gets global nemonoxacin rights

11-12-2011

Taiwan’s TaiGen Biotechnology has reached a deal with Ireland-headquartered Warner Chilcott (Nasdaq:…

Antibiotics and Infectious diseasesBiotechnologyLicensingnemonoxacinPharmaceuticalTaiGen BiotecnologyWarner Chilcott

EUnetHTA position paper developed

11-12-2011

The European Network for Health Technology Assessment (EUnetHTA) Joint Action Conference in Gdansk, Poland,…

BiotechnologyEuropeRegulation

MAbs largest class of biotherapeutics

08-12-2011

Monoclonal antibodies (MAbs) were the fastest growing segment in the global pharmaceutical market in…

BiotechnologyMarkets & Marketing

FDA plans biosimilars user fee talks

08-12-2011

The US Food and Drug Administration has published a Federal Register notice announcing a December 16…

BiotechnologyFinancialGenericsNorth AmericaRegulation

Dendreon cashes in Victrelis royalty

08-12-2011

US pharma company Dendreon (Nasdaq: DNDN) says that it has agreed to sell for $125 million in cash its…

Anti-viralsBiotechnologyDendreonFinancialLicensingMerck & CoOncologyPharmaceuticalProvengeVictrelis

FDA eases REMS requirements for Amgen’s Nplate and GSK’s Promacta

07-12-2011

The US Food and Drug Administration says that an agency initiated review of the current information has…

AmgenBiotechnologyGlaxoSmithKlineNorth AmericaNplatePharmaceuticalPromactaRare diseasesRegulation

Novartis in licensing deal with Cellectis; pays milestone to GenVec

07-12-2011

Paris, France-based Cellectis genome engineering specialist (Alternext: ALCLS) has signed a license agreement…

BiotechnologyCellectisGenVecLicensingNeurologicalNovartisPharmaceutical

UK government boost to life science industry includes early access to news drugs

06-12-2011

A multi million pound package of measures were outlined by the Prime Minister David Cameron to support…

BiotechnologyEuropeFinancialHealthcarePharmaceuticalPoliticsResearch

European experts call for a simplified and coherent clinical trials framework

04-12-2011

Key stakeholders gathered in the European Parliament last week to debate proposals on improving the clinical…

BiotechnologyEuropePharmaceuticalRegulationResearch

US Biotech scores wins in November, despite global economic turmoil, says Burrill

04-12-2011

Economic and political worries in Europe and the USA fuelled another month of wild gyrations in the stock…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaResearch

Inhibitors of infamous Ras oncogene reported by Genentech researchers

04-12-2011

A drug discovery team at Genentech, a subsidiary of Swiss drug major Roche (ROG: SIX) has uncovered a…

BiotechnologyGenentechOncologyPharmaceuticalResearchRoche

Horizon 2020 – We all pay but who gets the returns? asks HAI

01-12-2011

At the same time as the European Commission presented its Research and Innovation Framework program -…

BiotechnologyEuropePharmaceuticalResearch

European Commission proposes 80 billion-euro investment in research and innovation

01-12-2011

A package of measures to boost research, innovation and competitiveness in Europe, under the banner of…

BiotechnologyEuropeFinancialPharmaceuticalResearch

Santaris prevails in patent battle with Isis Pharma

30-11-2011

Denmark-based RNA-targeted therapies developer Santaris Pharma A/S says that it has won two significant…

BiotechnologyIsis PharmaceuticalsNorth AmericaPatentsSantaris Pharma

2301 to 2325 of 2381 results

Back to top